Lite Strategy, Inc. Capital Units, Authorized
Lite Strategy, Inc. (LITS) had Capital Units, Authorized of 226.10 million shares as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Notes
us-gaap:CapitalUnitsAuthorized · last filed 2026-05-13
- 2026-03-31: Capital Units, Authorized 226.10M shares.
- 2025-12-31: Capital Units, Authorized 226.10M shares.
- 2025-09-30: Capital Units, Authorized 226.10M shares.
- 2025-06-30: Capital Units, Authorized 226.10M shares.
| Period end | Capital Units, Authorized |
|---|---|
| 2026-03-31 | 226.10M shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 226.10M shares 10-Q · filed 2026-02-17 |
| 2025-09-30 | 226.10M shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 226.10M shares 10-K · filed 2025-09-26 |
| 2025-03-31 | 226.10M shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 226.10M shares 10-Q · filed 2025-02-12 |
| 2024-09-30 | 226.10M shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 226.10M shares 10-K · filed 2024-09-19 |
| 2024-03-31 | 226.10M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 226.10M shares 10-Q · filed 2024-02-13 |
| 2023-09-30 | 226.10M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 226.10M shares 10-K · filed 2023-09-26 |
| 2022-06-30 | 226.10M shares 10-K · filed 2022-09-08 |
| 2021-06-30 | 226.10M shares 10-K/A · filed 2022-05-23 |
| 2020-06-30 | 226.10M shares 10-K · filed 2020-09-09 |
| 2019-06-30 | 226.10M shares 10-K · filed 2019-08-28 |
| 2018-06-30 | 113.10M shares 10-K · filed 2018-08-30 |
| 2017-06-30 | 113.10M shares 10-K · filed 2017-09-05 |
| 2016-06-30 | 113.10M shares 10-K · filed 2016-09-06 |
| 2015-06-30 | 113.10M shares 10-K · filed 2015-09-02 |
| 2014-06-30 | 113.10M shares 10-K · filed 2014-09-09 |
| 2013-06-30 | 113.10M shares 10-K · filed 2013-09-18 |
| 2012-06-30 | 113.10M shares 10-K · filed 2012-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |